c-Myc-Mediated Epigenetic Silencing of MicroRNA-101 Contributes to Dysregulation of Multiple Pathways in Hepatocellular Carcinoma
Lei Wang(University of Electronic Science and Technology of China), Angang Yang(Henan Medical University), Weihong Wen(Northwestern Polytechnical University), Lintao Jia(Air Force Medical University), Xiang Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhe Wang(The Nature Conservancy), Rui Zhang(Air Force Medical University), Tao Wang(Air Force Medical University), Daiming Fan(National Clinical Research Center for Digestive Diseases), Yongzhan Nie(Xijing Hospital), Jiandong Yang(National Institute on Aging), Dou Ke-feng(Xijing Hospital), Si–Yi Chen(University of Southern California), Jun Zhao(Chinese Academy of Sciences), Jing Zhao(Northwestern Polytechnical University), Rui‐An Wang(Vaughn College of Aeronautics and Technology), Yan–Ling Meng, Sijung Hu(Xijing Hospital)
Cited by 163
Related Papers
lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
|Nature Medicine|2017|460
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
|Nature Communications|2021|414
Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives
|Protein & Cell|2018|251
Challenges in the management of acute peptic ulcer bleeding
|The Lancet|2013|234